National Institute on Aging
National Institutes of Health |
NIA Intramural-Home
NIH Clinical Trials-Home NIA Clinical Studies-Home |
NIA Clinical Studies |
Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia |
This study is currently recruiting. |
This phase II trial is studying how well giving bryostatin 1 together with rituximab works in treating patients with B-cell non-Hodgkin's lymphoma or chronic lymphocytic leukemia that has not responded to previous treatment with rituximab |
For More Information and to be Screened for Eligibility |
PLEASE CALL: 410-350-3939 - or - Register Online |
Email: NIAStudiesRecruitment@mail.nih.gov |
Additional information can be found at NIH ClinicalTrials.gov -1- and -2- |
Principal Investigator: William Ershler, M.D. NIA Study #: 2004-055 |
NIA - ASTRA Unit Advanced Studies in Translational Research on Aging |
Harbor Hospital 3001 Hanover Street Baltimore, MD 21225 |
IRP Home What's New Contact Us Accessibility Disclaimer Privacy Site Search Site Map NIA Home |